Table 2.
Outcomes achieved for each centre and statistical comparisons
| Centre | Comparison P‐value | |||||
|---|---|---|---|---|---|---|
| C1 | C2 | C3 | C4 | C5 | ||
| Evidence‐based clinical performance measures, n (%) | ||||||
| Kt/v ≥ 1.4 | 28 (70.0) | 29 (85.3) | 22 (51.2) | 46 (85.2) | 36 (87.8) | <0.001b |
| Hb 11‐13 g/dla | 21 (51.2) | 23 (62.2) | 23 (51.1) | 33 (61.1) | 23 (56.1) | 0.745b |
| Ca 8.4–10 mg/dl | 35 (85.4) | 32 (86.5) | 37 (82.2) | 45 (83.3) | 29 (70.7) | 0.363b |
| P 2.5‐4.5 mg/dl | 19 (46.3) | 17 (45.9) | 18 (40.0) | 32 (59.3) | 17 (41.5) | 0.324b |
| Functioning AAVF | 19 (46.3) | 27 (73.0) | 33 (71.7) | 42 (77.8) | 31 (75.6) | 0.011b |
| 1‐year hospitalization rate | 20 (48.8) | 20 (54.1) | 19 (40.4) | 16 (29.6) | 11 (26.8) | 0.045b |
| Mortality; % (SD) | ||||||
| 2‐year cumulative survival | 67.7 (7.4) | 58.4 (8.2) | 62.1 (7.3) | 78.5 (6.1) | 74.1 (7.1) | 0.264d |
| Health related quality of life (HRQoL); Mean (SD) | ||||||
| MCS from SF‐36 | 53.1 (14.6) | 46.8 (12.5) | 46.3 (15.8) | 49.1 (15.1) | 51.5 (15.4) | 0.393c |
| PCS from SF‐36 | 31.7 (9.5) | 33.0 (7.4) | 32.7 (10.3) | 35.4 (10.0) | 36.0 (9.2) | 0.340c |
| Patient satisfaction; Mean (SD) | ||||||
| DCQ | 91.6 (10.3) | 97.6 (6.0) | 88.4 (18.5) | 87.2 (16.4) | 86.8 (12.5) | 0.018c |
a
According to the recommendations at the moment data were collected.
b
X2 test.
c
Analysis of variance test.
d
Kaplan–Meier log‐rank test.
AAVF, Autologous arteriovenous fistula; Ca, Serum calcium; DCQ, Quality of Care in Dialysis Centre Questionnaire; Hb, Haemoglobin concentration; Kt/v, Dialysis adequacy was calculated with the single pool Daugirdas II method; MCS, Mental component summary from SF‐36 Questionnaire; P, Serum phosphorous; PCS, Physical component summary from SF‐36 Questionnaire.